The combination of relatlimab and nivolumab increased treatment-free survival compared to nivolumab alone in advanced melanoma patients. At 48 months, the combination therapy showed higher overall ...

The Kernel Vulnerability Capabilities (KVC) framework represents a paradigm shift in Windows security research, offering unprecedented access to modern Windows internals through sophisticated ring-0 ...